Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Optimal Hypertension Regimens (AIM HY-INFORM)
2016-000165-23Phase 4Unknown
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amlodipine, lisinopril, chlorthalidone and amiloride in hypertension (HTN), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Seated automated office systolic blood pressure. Status: unknown.
02
Drugs
amlodipinelisinoprilchlorthalidoneamiloride
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2016-000165-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000165-23.